JENNIFER HOLMAN: Open Payments
NPI 1447354626 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$73,947 in 143 payments from 12 companies in 2025. Trend: 2023 $54,748 · 2024 $83,448 · 2025 $73,947
Speaker / faculty: $55,250Travel & lodging: $15,175Food & beverage: $3,522
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 63 | $71,698 |
| REVANCE THERAPEUTICS, INC. | 16 | $599 |
| GENZYME CORPORATION | 18 | $561 |
| Galderma Laboratories, L.P. | 17 | $398 |
| Regeneron Healthcare Solutions, Inc. | 10 | $359 |
| UCB, Inc. | 7 | $129 |
| Organon LLC | 6 | $88 |
| PFIZER INC. | 2 | $30 |
| Incyte Corporation | 1 | $30 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $23 |
Products named: RINVOQ, SKYRIZI, DUPIXENT, DAXXIFY, NEMLUVIO, LIBTAYO, Bimzelx, DYSPORT.
Industry payments across TX — which companies pay providers there.
